Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
44,703,059
-
Shares change
-
+1,357,433
-
Total reported value, excl. options
-
$47,552,296
-
Value change
-
+$1,210,624
-
Put/Call ratio
-
247%
-
Number of buys
-
36
-
Number of sells
-
-31
-
Price
-
$1.06
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q3 2021
103 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q3 2021.
iBio, Inc. - Common Stock (IBIO) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,703,059 shares
.
Largest 10 shareholders include BlackRock Inc. (15,514,328 shares), VANGUARD GROUP INC (10,511,607 shares), STATE STREET CORP (4,585,809 shares), GEODE CAPITAL MANAGEMENT, LLC (4,100,969 shares), NORTHERN TRUST CORP (1,937,986 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,115,826 shares), Nuveen Asset Management, LLC (978,062 shares), Bank of New York Mellon Corp (727,537 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (532,143 shares), and Squarepoint Ops LLC (354,145 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.